Consistently, examining EMT markers demonstrated that U0126 treatment repressed the expression of MMP2, MMP9, N-cadherin, Vimentin, Snail, and Slug in Id3-overexpressing ESCC cells (Fig. 7C). This evidence concerns the gene MMP2 and esophageal squamous cell carcinoma.